Meet Britt, one of the many team members helping advance Total Artificial Heart technology at SynCardia.
Did you know? More than 2,100 SynCardia Total Artificial Hearts have been implanted in 27 countries, supporting patients with end-stage biventricular heart failure.
SynCardia is the manufacturer of the world's first and only FDA-approved Total Artificial Heart. We're proud to support clinicians and patients through continued innovation in heart replacement technology.
Artificial heart technology continues to evolve. This @IEEEEMBS Pulse article explores the engineering and innovation driving the next generation of artificial hearts.
Read more:
embs.org/pulse/articles/engi…
#ArtificialHeart #MedTech #BiomedicalEngineering
Life with the Freedom® Driver means more than mobility. It means time with family, moments outside the hospital, and the ability to continue moving forward while waiting for a heart transplant.
These photos highlight real STAH patients supported with the Freedom® Driver System.
Step inside the SynCardia Total Artificial Heart patient journey, from implant through recovery, and see how advanced mechanical circulatory support helps patients return to what matters most.
Missed it yesterday?
The first cardiovascular episode of The Crux of MedTech isn’t about products or markets. It explores what changes when a clinician becomes the patient—and how decisions are made when outcomes are uncertain.
🎧 lnkd.in/eanXDQp9
We honor Dr. Peter Heimes, whose invention of the Heimes Driver made portable support for Total Artificial Heart patients possible. His work inspired today’s Freedom Driver system. We carry forward his vision—saving lives, one heart at a time.
We’re headed to the AHA Scientific Sessions in Louisiana next week! #AHA25 ❤️
Visit Booth 3408 to connect with the @SynCardia team and learn how the Total Artificial Heart is helping give patients with end-stage heart failure a second chance at life.
Our @SynCardia Total Artificial Heart is featured on 9-1-1, now streaming on @Hulu!
Catch S6E1: “Let the Game Begin” and see life-saving innovation in action.
We had a wonderful time exhibiting at the @UCSF Update on Heart Failure Therapies 2025 in beautiful Sonoma, CA. Thank you to UCSF for hosting such a valuable gathering!
Join us in New York to hear from Patrick and learn more about how Picard Medical and SynCardia are driving innovation in advanced heart failure treatment.
🔗 Event info: hcwevents.com/annualconferen…
SynCardia CEO Patrick NJ Schnegelsberg will speak at the H.C. Wainwright Global Investment Conference on Sept. 10 at 1:30 PM. Hear how we’re advancing the world’s only FDA-approved Total Artificial Heart.
hcwevents.com/annualconferen…
SynCardia Total Artificial Heart retweeted
SynCardia CEO Patrick NJ Schnegelsberg will speak at the H.C. Wainwright Global Investment Conference on Sept. 10 at 1:30 PM. Hear how we’re advancing the world’s only FDA-approved Total Artificial Heart.
hcwevents.com/annualconferen…
SynCardia CEO Patrick NJ Schnegelsberg will speak at the H.C. Wainwright Global Investment Conference on Sept. 10 at 1:30 PM. Hear how we’re advancing the world’s only FDA-approved Total Artificial Heart.
hcwevents.com/annualconferen…
Big smiles from our team at VADapalooza!
Proud to join other innovators in supporting VAD teams and the patients they care for.
#syncardia #syncardiacares
Helping students start strong. 💪📚
The SynCardia team donated supplies + field trip funds to Utterback Middle School last week.
Proud to give back; one backpack, one student at a time. ❤️
#SynCardia #backtoschool
Steve Zamojski and Mark Snider are connecting with cardiothoracic surgeons to share real-world insights and discuss how the SynCardia Total Artificial Heart (STAH) makes a difference in the lives of patients with end-stage biventricular heart failure.
sacsconference.com/
SynCardia is honored to take part in the SACS Annual Meeting. This premier gathering brings together the nation’s leading cardiothoracic surgeons and healthcare professionals.
sacsconference.com/
#SynCardia #PicardMedical #Givingthegiftoftime
SynCardia was conceived during America's original medical moonshots—the 1960s push to develop a Total Artificial Heart. Since then, we have turned that bold vision into something real, practical, and lifesaving.
biztechoutlook.com/pioneerin…
Happy #InternationalWomenInEngineeringDay! 👩🔧
Today we celebrate the women engineers at SynCardia and around the world who are powering progress in cardiac care and innovation. Here’s to building the future—one heart at a time. 💙
#SynCardia #WomenInSTEM #STAH #HeartFailure















